Facebook
Twitter
LinkedIn
Forward
Viral Cancers and Community Outreach and Engagement
This Symposium is designed to provide state-of-the-art information on the etiologies, mechanisms of oncogenesis of cancer viruses, as well as clinical associated viral cancers, and current detection, prevention, vaccination and treatments to audience of academic and private physicians and nurses, basic scientists, and community.
Target Audience
Local, national and international academic and private physicians and nurses, and basic scientists as well as other appropriate health care professionals and the community.
Learning Objectives
- Learn the basic knowledge on cancer viruses and viral cancers.
- Learn the basic knowledge on the epidemiology and natural history of cancer viruses and viral cancers.
- Learn the knowledge on the vaccination of cancer viruses.
- Learn the knowledge on the mechanism of oncogenesis induced by cancer viruses.
- Learn the knowledge on the prevention and care of viral cancers.
Additional Information
| Attachment | Size |
|---|---|
 Viral Oncology Symposium Program DRAFT 9-29-23 2.pdf | 3.81 MB |
Symposium Program:
7:30-8:00 Registration and Breakfast
8:00-8:05 Opening, Shou-Jiang (SJ) Gao, PhD, Co-Leader of Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh Foundation Endowed Chair in Drug Development for Immunotherapy, and Professor of the Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine
8:05-8:15 Robert Ferris, MD, PhD, Director, UPMC Hillman Cancer Center, Hillman Professor of Oncology, Associate Vice Chancellor for Cancer Research, Co-Director, Tumor Microenvironment Center, Professor of Otolaryngology, of Immunology, and of Radiation Oncology, University of Pittsburgh
“Welcome Remarks”
8:15-8:30 Anantha Shekhar, MD, PhD, Senior Vice Chancellor for the Health Sciences and John and Gertrude Petersen Dean, School of Medicine, University of Pittsburgh
“Welcome Remarks”
Section 1: Viral cancers and vaccines, Section Chair: Patrick Moore, MD, MPH
8:30-9:15 Douglas R. Lowy, MD, Deputy Director, National Cancer Institute
“Controlling HPV-Associated Cancers Through Vaccination and Screening”
9:15-10:00 Blossom Damania, PhD, Boshamer Distinguished Professor, Vice Dean for Research University of North Carolina at Chapel Hill
“Oncogenic human herpesviruses”
10:00-10:45 Jeffrey I. Cohen, MD, Chief, Laboratory of Infectious Diseases; Chief, Medical Virology Section, National Institute of Health “Use of Vaccines and Monoclonal Antibodies to Prevent Epstein-Barr Virus Infection/Disease”
10:45-11:00 Break
Section 2: Keynote presentation by Nobel Prize Laureate Dr. Charles M. Rice, Section Chair: Haitao Guo, PhD
11:00-12:00 Charles M. Rice, PhD, 2020 Nobel Prize Laureate, Maurice R. and Corinne P. Greenberg Professor in Virology, The Rockefeller University
“Chronic viral hepatitis and cancer: Insights from promising new models and approaches”
12:00-1:00 Lunch
Section 3: Viral oncogenesis and anti-viral, Section Chair: Yuan Chang, MD
1:00-1:20 Haitao Guo, PhD, Professor and Co-Leader, Cancer Virology Program, UPMC Hillman Cancer Center
“Epigenetic regulation of HBV cccDNA minichromosome and antiviral approach”
1:20-1:40 Masa Shuda, PhD, Assistant Professor, Cancer Virology Program, UPMC Hillman Cancer Center “Why does Merkel cell polyomavirus cause cancers with a Merkel cell phenotype?”
1:40-2:00 Renfeng Li, PhD, Associate Professor, Cancer Virology Program, UPMC Hillman Cancer Center
“Decoding EBV reactivation: unleashing therapeutic potential against virus-associated cancers”
2:00-2:20 Kathy Shair, PhD, Assistant Professor, Cancer Virology Program, UPMC Hillman Cancer Center “Towards reducing the burden of nasopharyngeal carcinoma by studying the molecular properties of Epstein-Barr virus”
2:20-2:50 Robert Ferris, MD, PhD, Director, UPMC Hillman Cancer Center, Hillman Professor of Oncology, Associate Vice Chancellor for Cancer Research, Co-Director, Tumor Microenvironment Center, Professor of Otolaryngology, of Immunology, and of Radiation Oncology, University of Pittsburgh “Optimizing standard and innovative therapies for HPV+ head and neck cancer ”
2:50-3:00 Break
Section 4: Community Outreach and Engagement of viral cancers, Section Chair: Monica Baskin, PhD
3:00-3:30 Jose Zevallos, MD, MPH, Professor and Chairman, Department of Otolaryngology, the Eugene N Myers, M.D. Professor, University of Pittsburgh School of Medicine
“Clinical care of HPV-associated cancer”
3:30-4:00 Chari Cohen, PhD, President, Hepatitis B Foundation
“Strategies for Community Engagement on Hepatitis B and Liver Cancer”
4:00-4:30 Shannon Christy, PhD, Assistant Member, Department of Health Outcomes and Behavior, Moffitt Cancer Center
“Conducting community-engaged HPV vaccination research”
4:30-5:00 Monica Baskin, PhD, Assistant Vice Chancellor for Community Health Equity, Health Sciences, Professor of Medicine, Division of Hematology/Oncology, School of Medicine, Associate Director of Community Outreach and Associate Director of Health Equity, Hillman Cancer Center “Community Engagement around Viruses and Vaccines: Who, what, when and why?”
5:00-5:30 Marty Griffin, Cancer survival advocate, American investigative reporter and radio talk show host, KDKA-TV and KDKA-AM radio in Pittsburgh “Cancer survival” No CME credit awarded
5:30-5:40 Closing ceremony
5:40 Adjournment
5:40-6:30 Reception
Travel
Parking:
Parking is available at The Assembly garage on Morewood Avenue between Centre Avenue and Baum Boulevard. Parking is at your own expense.
Organization Committee:
Monica Baskin
Robert Ferris
Shou-Jiang Gao
Haitao Guo
Patrick Moore
Contact:
Dr. Shou-Jiang (SJ) Gao at: gaos8@upmc.edu
Greg Benzy at benzyg@upmc.edu
Faculty Dislosure:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships for the individuals listed below have been mitigated
Chari Cohen, PhD
Grant/Research Support: Gilead Sciences, VBI Vaccines, GSK, BMS, Antios
Other: Patient Advisory Council: Gilead Sciences, GSK, Roche
Robert Ferris, MD, PhD
Grant/Research Support:
Astra-Zeneca/MedImmune: Clinical Trial, Research Funding
Bristol-Myers Squibb: Advisory Board, Clinical Trial, Research Funding
Coherus BioSciences, Inc.: Advisory Board
Eisai Europe Limited: Advisory Board
Genmab: Advisory Board
Hookipa Biotech GmbH: Advisory Board
Instil Bio, Inc: Advisory Board
Lifescience Dynamics Limited: Advisory Board
MacroGenics, Inc.: Advisory Board
MeiraGTx, LLC: Advisory Board
Merck: Advisory Board, Clinical Trial
Mirror Biologics Inc: Data Safety Monitoring Board
Numab Therapeutics AG: Advisory Board
OncoCyte Corporation: Advisory Board
Pfizer: Advisory Board
Rakuten Medical, Inc: Advisory Board
Seagen, Inc: Advisory Board
SIRPant Immunotherapeutics, Inc: Advisory Board
Tesaro: Research Funding
Vir Biotechnology, Inc: Advisory Board
Consultant: Adagene Incorporated Aduro Biotech, Inc; Bicara Therapeutics, Inc; Brooklyn Immunotherapeutics LLC; Catenion EMD Seron
Charles M Rice, PhD
Grant/Research Support: Vir, GSK
Consultant: Vir, Arbutus
Stockholder (privately held): Invisishield, Apath
Stockholder (publicly traded): Vir
Anatha Shekhar, MD, PhD
Stockholder (publicly traded): Karuna Therapeutics, Aardwolf Therapeutics
Other: Co-Founder: Anagin, Inc.; Gate Neurosciences; MindX Sciences; Vasulonics, LLC; Monument Therapeutics
Jose Zevallos, MD, MPH
Other: Ownership Interest (Droplet Bioscience, LLC). Advisory Board (Vine Medical)
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 7.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 7.50 Attendance
Thank you to the following companies for their support.
We gratefully acknowledge the following exhibitors for their participation in this activity:
Bronze Level:
Gilead
Merck
Contributors Level:
AbbVie
American Cancer Society
Amgen
GSK
Leukemia Lymphoma Society
Pfizer Oncology
QUESTIONS?
Contact: Brittni Prosdocimo
Phone: 412-623-3671
E-mail: bittnerb@upmc.edu